Patients with cancer have a higher risk of severe coronavirus disease (COVID-19) and
associated mortality than the general population. Owing to this increased risk, patients with …

Background Patients with cancer are considered a priority group for Severe Acute
Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) vaccination given their high risk of …

Importance Limited data have been presented to examine breakthrough SARS-CoV-2
infections, hospitalizations, and mortality in vaccinated patients with cancer in the US …

Importance It has become common practice to offer immunocompromised patients with
hematologic cancers a third COVID-19 vaccination dose, but data substantiating this are …

Background Illness after infection with the severe acute respiratory syndrome coronavirus 2
(SARS-CoV-2) Omicron variant is less severe compared with previous variants. Data on the …

Summary Background The omicron (B. 1.1. 529) variant of SARS-CoV-2 is highly
transmissible and escapes vaccine-induced immunity. We aimed to describe outcomes due …

Background An urgent need exists to improve the suboptimal COVID-19 vaccine response
in kidney transplant recipients (KTRs). We aimed to compare three alternative strategies with …

Immune responses following third COVID-19 vaccination are reduced in patients with
hematological malignancies compared to patients with solid cancer: Cancer Cell Skip to Main …

Vaccination guidelines for patients treated for hematological diseases are typically
conservative. Given their high risk for severe COVID-19, it is important to identify those …

Background Vaccines can be less immunogenic in people living with HIV (PLWH), but for
SARS-CoV-2 vaccinations this is unknown. In this study we set out to investigate, for the …